
Early lung cancer data back J&J’s Monarch Vantage
Interim data from the first human trial of the Monarch platform developed by Johnson & Johnson’s subsidiary Auris Health suggests the robotic endoscopy …

Early lung cancer data back J&J’s Monarch Vantage
Interim data from the first human trial of the Monarch platform developed by Johnson & Johnson’s subsidiary Auris Health suggests the robotic endoscopy …